Brief: Spyre Therapeutics Announces Pricing Of Upsized $403 Million Public Offering Of Common Stock
15/04/2026 03:38
April 14 (Reuters) - Spyre Therapeutics Inc SYRE.O: SPYRE THERAPEUTICS ANNOUNCES PRICING OF UPSIZED $403.0 MILLION PUBLIC OFFERING OF COMMON STOCK SPYRE THERAPEUTICS INC - PRICES PUBLIC OFFERING OF 6.5 MILLION SHARES AT $62.00 PER SHARE Source text: ID:nGNX6Vt3F0 Further company coverage: SYRE.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Spyre Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
U.S. STOCKS ON THE MOVE-Constellation Energy, AMD
U.S. STOCKS ON THE MOVE-MYR Group, Spyre Therapeutics, AMD
Spyre Therapeutics slips on $350 mln share sale
Brief: Spyre Therapeutics Announces Pricing Of $350.0 Million Public Offering Of Common Stock